Biological perspectives. Serotonin and norepinephrine reuptake inhibitors (SNRIs): venlafaxine and duloxetine

Perspect Psychiatr Care. 2006 May;42(2):144-8. doi: 10.1111/j.1744-6163.2006.00064.x.
No abstract available

Publication types

  • Case Reports

MeSH terms

  • Adrenergic Uptake Inhibitors / adverse effects
  • Adrenergic Uptake Inhibitors / therapeutic use*
  • Adult
  • Cyclohexanols / adverse effects
  • Cyclohexanols / therapeutic use*
  • Depressive Disorder, Major / drug therapy*
  • Duloxetine Hydrochloride
  • Female
  • Humans
  • Norepinephrine / metabolism*
  • Selective Serotonin Reuptake Inhibitors / adverse effects
  • Selective Serotonin Reuptake Inhibitors / therapeutic use*
  • Thiophenes / adverse effects
  • Thiophenes / therapeutic use*
  • Venlafaxine Hydrochloride

Substances

  • Adrenergic Uptake Inhibitors
  • Cyclohexanols
  • Serotonin Uptake Inhibitors
  • Thiophenes
  • Venlafaxine Hydrochloride
  • Duloxetine Hydrochloride
  • Norepinephrine